Award
Delivery Order #SPE2DR26FV9DY
AmerisourceBergen Delivery Order for Essential Insulin Vial
Buyer
Defense Logistics Agency
Award Amount
$113.70
Ceiling
$113.70
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26FV9DY
NAICS
325411
This award is a delivery order contract executed under the existing indefinite delivery vehicle held by AmerisourceBergen Drug Corp., a leading pharmaceutical distribution company. AmerisourceBergen is tasked with supplying a specific pharmaceutical product, Novolin R 100 Unit/mL Vial 10mL, a type of insulin essential for diabetes management. The contract plays a significant role in ensuring that vital medications are readily accessible to support federal health programs and public healthcare needs. The scope of work involves the timely delivery of this critical medication to a designated location in Conshohocken, Pennsylvania, over a short, precise timeframe. This delivery order benefits from the competitive and flexible procurement structure established by the parent IDV contract, facilitating efficient pharmaceutical distribution. The award reflects an ongoing commitment to maintaining a consistent supply chain for essential medicines with a scheduled delivery in March 2026.
Description
4571154376!NOVOLIN R 100 UNIT/ML VIAL 10ML